Study of EVO756 in Adults With Migraine
Clinical trial NCT07616128 · RECRUITING
Trial details
- NCT number
- NCT07616128
- Sponsor
- Evommune, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-29
- Primary completion
- 2027-10-01
- Enrollment
- 330
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.